Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches
09:49

Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches

Published on: March 17, 2013

Erythrocyte patch for enhanced B cell depletion therapy.

Jiaqi Liu1, Fengju Wang1, Lian Li1

  • 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

Science Advances
|May 20, 2026
PubMed
Summary

CD20 EryPatches offer a novel dual-action therapy for B cell malignancies and autoimmune diseases. This innovative approach enhances B cell depletion through mechanotransduction and phagocytic tagging, outperforming current treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting mitocytosis potentiates mitochondria drug delivery for antimetastasis therapy.

Science advances·2026
Same author

Surface hydrophobicity and rigidity determines protein corona on orally delivered nanoparticles treating colitis.

Nature communications·2026
Same author

CXCR4 Clustering Induced by Polymeric Nanothreads Impedes Cancer Cell Metastasis via PIEZO1-Mediated Mechanotransduction.

Advanced healthcare materials·2025
Same author

Enhance Efferocytosis and Block the Macrophages-Platelets Feedback Loop for Targeted Treatment of Psoriasis.

ACS nano·2025
Same author

Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment.

Science advances·2025
Same author

A Two-Pronged Delivery Strategy Disrupting Positive Feedback Loop of Neutrophil Extracellular Traps for Metastasis Suppression.

ACS nano·2024

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Immunology and Hematology

Background:

  • Dysregulated B cells drive hematologic malignancies and autoimmune diseases.
  • Current B cell therapies struggle with effective signaling and depletion.
  • CD20 is a key target for B cell-related disorders.

Purpose of the Study:

  • To develop a novel cellular therapy, CD20 EryPatch, for enhanced B cell depletion.
  • To leverage erythrocyte natural processes for a dual-action therapeutic mechanism.
  • To improve upon existing CD20-targeted therapies.

Main Methods:

  • CD20 EryPatches were engineered to adhere to B cells via CD20 receptors.
  • The patch utilizes morphological changes (discocyte-to-echinocyte transition) for mechanotransduction and CD20 cross-linking.

More Related Videos

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Related Experiment Videos

Last Updated: May 22, 2026

Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches
09:49

Isolating And Immunostaining Lymphocytes and Dendritic Cells from Murine Peyer's Patches

Published on: March 17, 2013

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

  • Biomarker alteration transforms the patch into a "eat me" tag, initiating erythrophagocytosis.

    • Main Results:

    • CD20 EryPatches demonstrated enhanced B cell depletion compared to standard CD20 monoclonal antibodies.
    • The dual mechanism of mechanotransduction and "tag-and-clear" significantly amplified apoptosis in target B cells.
    • Erythrophagocytosis was successfully initiated, facilitating B cell clearance.

    Conclusions:

    • CD20 EryPatch presents a promising new strategy for treating B cell disorders.
    • The technology effectively targets B cells through combined physical and biological mechanisms.
    • This approach shows potential for improved efficacy in non-Hodgkin lymphoma, lupus, and rheumatoid arthritis.